NCT02358473 2024-09-19Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung CancerKyowa Kirin Co., Ltd.Phase 1 Completed13 enrolled 10 charts
NCT04185220 2023-01-04Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary SyndromeNational Institutes of Health Clinical Center (CC)Phase 1 Completed6 enrolled 16 charts
NCT02444793 2019-02-27A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsPfizerPhase 1 Terminated24 enrolled 34 charts
NCT00355472 2012-10-18Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCLKyowa Kirin Co., Ltd.Phase 1 Completed16 enrolled 12 charts